Evidence map›Paper›PMID 38126047›Full record

ArticleJournal of cardiology cases2023

Perioperative immunosuppressive therapy and coronary ostial angioplasty for unstable angina with Takayasu arteritis.

Takeshi Shimizu, Satoshi Abe, Tomoyuki Asano, Takashi Kaneshiro, Atsushi Kobayashi, Takayoshi Yamaki, Kazuhiko Nakazato, Shuichiro Takanashi, Mitsuaki Isobe, Yasuchika Takeishi

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of cardiology cases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Takeshi ShimizuDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Satoshi AbeDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Tomoyuki AsanoDepartment of Rheumatology, Fukushima Medical University, Fukushima, Japan.
Takashi KaneshiroDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Atsushi KobayashiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Takayoshi YamakiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Kazuhiko NakazatoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Shuichiro TakanashiDepartment of Cardiovascular Surgery, Sakakibara Heart Institute, Tokyo, Japan.
Mitsuaki IsobeDepartment of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.
Yasuchika TakeishiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Fukushima Medical University · JPSakakibara Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A young female patient with Takayasu arteritis presented with unstable angina due to bilateral coronary artery involvement. Steroid pulse therapy and subsequent prednisolone administration were started, but early coronary artery bypass grafting was required because of the multiple angina attacks at rest, with a prednisolone dose of 22.5 mg (0.45 mg/kg/day). Since the left internal thoracic artery which was grafted to the left anterior descending artery resulted in graft failure a few days after the surgery, the immunosuppressive therapy was intensified with the addition of tocilizumab and methotrexate. After controlling the disease activity, coronary ostial angioplasty using external iliac artery grafts was successfully performed, with a prednisolone dose of 15 mg (0.3 mg/kg/day). Ten months after the operation, the patient has been free from chest pain. The present case demonstrated the importance of adequate preoperative immunosuppressive therapy, even when early surgical intervention is required. Learning objective: There are no established treatment regimens for immunosuppressive management in cases of Takayasu arteritis (TAK) requiring immediate surgical intervention. Even when early surgery is required, it is important to reduce disease activity with appropriate preoperative immunosuppressive therapy using steroids in addition to biological agents, such as tocilizumab. Coronary ostial angioplasty is the effective surgical revascularization technique for TAK with coronary artery involvement.

Indexed as

Coronary ostial angioplastySteroidTakayasu arteritisTocilizumabUnstable angina

Identifiers

PMID38126047
PMCPMC10730271
OpenAlexW4386370791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.